-1366x0.jpg)
This year's conference focused on the theme "Cancer Genetics and Updates on Advances in Medical Genetics and Genomics," featuring continuous medical education (CME) programs and an official scientific conference that included over 40 presentations on the latest and most in-depth knowledge in the field of medical genetics. The conference welcomed the participation of many genetic experts from both within and outside Vietnam, including Assoc. Prof. Dr. Tran Duc Phan, Assoc. Prof. Dr. Luong Thi Lan Anh, Assoc. Prof. Dr. Tran Van Khoa, Assoc. Prof. Dr. Nguyen Viet Nhan, Assoc. Prof. Dr. Vu Chi Dung, Prof. Dr. Kazuto Kato - Member of the WHO Genetic Advisory Board; Head of the Department of Biomedical Ethics and Social Policy at Osaka University, Prof. Dr. Dominique P. GERMAIN - University of Versailles, Raymond Poincaré University Teaching Hospital…
GENTIS was honored to accompany the conference and introduce to the delegates its comprehensive genetic testing ecosystem in the field of reproductive support using next-generation sequencing technology with the presentation titled "Application of Next-Generation Sequencing in Preimplantation Screening of Microdeletions and Duplications in Embryos" delivered by Dr. Pham Dinh Minh - Director of the GENTIS Genetic Counseling Center during the session "Updates on Advances in Genomic Medicine in Obstetrics 1."
According to Dr. Pham Dinh Minh, microdeletions and duplications in chromosomes are small chromosomal structural abnormalities that can lead to conditions including physical developmental delays, intellectual disabilities, and congenital defects. With the current preimplantation genetic testing for structural rearrangements (PGT-SR) having a resolution of 5-10Mb, smaller structural abnormalities may be missed, leading to severe consequences.
GENTIS is applying next-generation sequencing technology in preimplantation genetic screening for microdeletions and duplications in embryos. Particularly, the PGT-MAX 1 test helps detect abnormalities in the quantity of 24 chromosomes, identifies chromosomal structural abnormalities as small as 2Mb, such as 22q11.2 deletion (DiGeorge syndrome), 1p36 deletion (1p36 deletion syndrome), and other common microdeletions/duplications, and detects mosaicism (20-80%). By reducing the survey gap from 5Mb to 2Mb, the PGT-MAX1 test offers an improved solution for surveying chromosomal structural abnormalities in embryos.
Dr. Pham Dinh Minh's report demonstrated that the application of next-generation sequencing technology in preimplantation genetic screening has enhanced the effectiveness of screening for chromosomal structural abnormalities in embryos, thereby increasing the chances of successful pregnancy and healthy childbirth.
As a sponsor of the conference, GENTIS also exhibited and introduced many materials and product information on PGT in particular and GENTIS testing services in general to experts and doctors. When visiting the GENTIS booth, delegates also participated in a minigame, a lucky spin, and received valuable gifts.
The 2nd Congress of the Vietnam Society of Medical Genetics and the 2024 National Scientific Conference of the Vietnam Society of Medical Genetics provided a valuable opportunity for GENTIS to update its knowledge, engage with the international community on cancer genetics, medical genomics, and reproductive medicine. This allowed GENTIS to interact with numerous experts, introduce meaningful and practical genetic tests, and present the scientific research of its professional team to more than 500 attending delegates.
The conference was indeed a beneficial environment and an opportunity for doctors to share information, exchange knowledge, engage in scientific research, and practice to continuously improve the quality of patient care, aiming for international integration. GENTIS will continue to research and launch useful genetic tests to best support doctors in diagnosing and treating diseases.
